Vir Biotechnology (VIR) Operating Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.61 Mn |
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | -6.25 Mn |
| Jun 30, 2025 | -515,181.00 |
| Mar 31, 2025 | -365,573.00 |
| Dec 31, 2024 | 877,191.00 |
| Sep 30, 2024 | -455,996.00 |
| Jun 30, 2024 | -500,380.00 |
| Mar 31, 2024 | 67,322.00 |
| Dec 31, 2023 | 624,775.00 |
| Sep 30, 2023 | -140,860.00 |
| Jun 30, 2023 | -543,954.00 |
| Mar 31, 2023 | 7,687.00 |
| Dec 31, 2022 | -35,665.00 |
| Sep 30, 2022 | 60,639.00 |
| Jun 30, 2022 | -63,660.00 |
| Mar 31, 2022 | 1,191.00 |
| Dec 31, 2021 | 12,187.00 |
| Sep 30, 2021 | -8,778.00 |
| Jun 30, 2021 | 806,424.00 |
| Mar 31, 2021 | -177,631.00 |
| Dec 31, 2020 | -170,733.00 |
| Sep 30, 2020 | -447,725.00 |
| Jun 30, 2020 | 119,052.00 |
| Mar 31, 2020 | 524,841.00 |
| Dec 31, 2019 | -310,759.00 |
| Sep 30, 2019 | -165,105.00 |
| Jun 30, 2019 | -90,691.00 |
| Mar 31, 2019 | 1,672.00 |
| Dec 31, 2018 | 33,330.00 |